Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Huber

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Journal of Vascular Surgery|July 25, 2018
Invited commentaryThomas S Huber
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 22, 2019
Surgeon Characteristics and Arteriovenous Fistula Maturation SuccessThomas S Huber
Journal of Vascular Surgery|July 20, 2024
VISIT may not solve the vascular surgery residency match challengesThomas S Huber
Journal of Vascular Surgery|August 20, 2014
Professionalism and the work-life balanceThomas S Huber
JAMA Surgery|March 5, 2015
A call to action for pre-end-stage renal disease careThomas S Huber
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 25, 2017
Novel Endovascular Access Trial: The Wave of the Future or Just Another Neat Technique?Thomas S Huber
Journal of Vascular Surgery|November 23, 2021
FEVAR and BEVAR: The new standard for comparison - Defining what is possibleThomas S Huber
Journal of Vascular Surgery|May 24, 2023
Attempting to define a role for renal artery stenting: Another analysis of the CORAL trialThomas S Huber
Journal of Vascular Surgery|August 27, 2018
Invited commentaryThomas S Huber
Perspectives in Vascular Surgery and Endovascular Therapy|December 20, 2008
Commentary. Anand, Yusuf, Xie, et al. The Warfarin Antiplatelet Vascular Evaluation Trial Investigators. Oral anticoagulation and antiplatelet therapy and peripheral arterial disease. N Engl J Med. 2007;357:217-227Thomas S Huber
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Journal of Vascular Surgery|July 25, 2018
Invited commentaryThomas S Huber
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 22, 2019
Surgeon Characteristics and Arteriovenous Fistula Maturation SuccessThomas S Huber
Journal of Vascular Surgery|July 20, 2024
VISIT may not solve the vascular surgery residency match challengesThomas S Huber
Journal of Vascular Surgery|August 20, 2014
Professionalism and the work-life balanceThomas S Huber
JAMA Surgery|March 5, 2015
A call to action for pre-end-stage renal disease careThomas S Huber
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 25, 2017
Novel Endovascular Access Trial: The Wave of the Future or Just Another Neat Technique?Thomas S Huber
Journal of Vascular Surgery|November 23, 2021
FEVAR and BEVAR: The new standard for comparison - Defining what is possibleThomas S Huber
Journal of Vascular Surgery|May 24, 2023
Attempting to define a role for renal artery stenting: Another analysis of the CORAL trialThomas S Huber
Journal of Vascular Surgery|August 27, 2018
Invited commentaryThomas S Huber
Perspectives in Vascular Surgery and Endovascular Therapy|December 20, 2008
Commentary. Anand, Yusuf, Xie, et al. The Warfarin Antiplatelet Vascular Evaluation Trial Investigators. Oral anticoagulation and antiplatelet therapy and peripheral arterial disease. N Engl J Med. 2007;357:217-227Thomas S Huber
Pageof 16